Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MG-98 enters clinical trials in MDS and AML

Jan. 30, 2002

Novel caspase inhibitors identified at Vertex

Jan. 29, 2002

Schering AG and Mologen to develop cell-based therapies

Jan. 29, 2002

Iressa under regulatory review in two major markets for NSCLC

Jan. 29, 2002

Human Genome Sciences submits IND for B-cell-targeting LymphoRad

Jan. 28, 2002

Cell Pathways updates phase IIa program of CP-461 in cancer

Jan. 28, 2002

Tubulin-binding agents from AstraZeneca with antiangiogenic activity

Jan. 25, 2002

FDA approval granted for Eligard 7.5 mg, formerly Leuprogel One-Month Depot

Jan. 25, 2002

Merck's European C225 program progresses as planned despite U.S. setback

Jan. 25, 2002

MVA-Muc1-IL-2 enters phase II trials in lung and breast cancers

Jan. 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...